AbbVie Braces For Busy Week Before $51B Shire Bid Deadline

AbbVie Inc. is staging a final push to swing rival drugmaker Shire PLC in favor of a $51 billion tie-up, a landmark offer that is reportedly picking up steam as the...

Already a subscriber? Click here to view full article